These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23084856)

  • 1. Interrelationship between HIV-1 fitness and mutation rate.
    Dapp MJ; Heineman RH; Mansky LM
    J Mol Biol; 2013 Jan; 425(1):41-53. PubMed ID: 23084856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations.
    Maldonado JO; Mansky LM
    Viruses; 2018 Jul; 10(7):. PubMed ID: 30029500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high cost of fidelity.
    Lloyd SB; Kent SJ; Winnall WR
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):8-16. PubMed ID: 24180375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation.
    Weber J; Chakraborty B; Weberova J; Miller MD; Quiñones-Mateu ME
    J Clin Microbiol; 2005 Mar; 43(3):1395-400. PubMed ID: 15750116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of replication fidelity in human immunodeficiency virus type 1.
    Furió V; Moya A; Sanjuán R
    Proc Biol Sci; 2007 Jan; 274(1607):225-30. PubMed ID: 17148251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.
    Li S; Ouyang J; Zhao B; An M; Wang L; Ding H; Zhang M; Han X
    BMC Infect Dis; 2020 Feb; 20(1):123. PubMed ID: 32046664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.
    White KL; Margot NA; Wrin T; Petropoulos CJ; Miller MD; Naeger LK
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3437-46. PubMed ID: 12384348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
    García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
    J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.
    Pham HT; Mesplède T; Wainberg MA
    Retrovirology; 2016 Apr; 13(1):31. PubMed ID: 27130466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.
    Hu Z; Giguel F; Hatano H; Reid P; Lu J; Kuritzkes DR
    J Virol; 2006 Jul; 80(14):7020-7. PubMed ID: 16809307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants.
    Collins JA; Thompson MG; Paintsil E; Ricketts M; Gedzior J; Alexander L
    J Virol; 2004 Jan; 78(2):603-11. PubMed ID: 14694092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture.
    Archer RH; Dykes C; Gerondelis P; Lloyd A; Fay P; Reichman RC; Bambara RA; Demeter LM
    J Virol; 2000 Sep; 74(18):8390-401. PubMed ID: 10954539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Q207D mutation in HIV type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness.
    Lu J; Whitcomb J; Kuritzkes DR
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):20-3. PubMed ID: 16123676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness.
    Kulkarni R; Babaoglu K; Lansdon EB; Rimsky L; Van Eygen V; Picchio G; Svarovskaia E; Miller MD; White KL
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):47-54. PubMed ID: 21997204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo.
    Lloyd SB; Lichtfuss M; Amarasena TH; Alcantara S; De Rose R; Tachedjian G; Alinejad-Rokny H; Venturi V; Davenport MP; Winnall WR; Kent SJ
    Virology; 2016 May; 492():1-10. PubMed ID: 26896929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions.
    Cong ME; Heneine W; García-Lerma JG
    J Virol; 2007 Mar; 81(6):3037-41. PubMed ID: 17192300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.
    Chunduri H; Rimland D; Nurpeisov V; Crumpacker CS; Sharma PL
    Virol J; 2011 Jan; 8():33. PubMed ID: 21255423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIV-1 reverse transcriptase mutants G190S and G190A, which confer resistance to non-nucleoside reverse transcriptase inhibitors, demonstrate reductions in RNase H activity and DNA synthesis from tRNA(Lys, 3) that correlate with reductions in replication efficiency.
    Wang J; Dykes C; Domaoal RA; Koval CE; Bambara RA; Demeter LM
    Virology; 2006 May; 348(2):462-74. PubMed ID: 16504235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility.
    Trivedi V; Von Lindern J; Montes-Walters M; Rojo DR; Shell EJ; Parkin N; O'Brien WA; Ferguson MR
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1291-300. PubMed ID: 18844463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.